BioNTech counts on shift to cancer drugs after second quarter losses quadruple
Go back to BioNTech counts on shift to cancer drugs after second quarter losses quadruple| (NASDAQ: BNTX) | Delayed: 90.32 -0.57 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.89 | 52 Week High | $ | |||
| Open | $89.89 | 52 Week Low | $ | |||
| Day High | $91.38 | P/E | N/A | |||
| Day Low | $89.71 | EPS | $ | |||
| Volume | 201,507 | |||||

